Grafa News and Videos — Page 115

Johnson & Johnson (NYSE:JNJ) reported 35% combined fistula remission at Week 48 with TREMFYA in its Phase 3 FUZION Crohn's disease trial.

Blackstone (NYSE:BX) closed its fifth energy transition private equity fund at US$8.7 billion, exceeding its predecessor's US$5.6 billion fundraising total by approximately 55%.

Dynex Capital (NYSE:DX) reported a negative 11.5% economic return for Q3 2026, as book value declined to $10.91 per share.

Merck (NYSE:MRK) agreed to acquire Silence Therapeutics (NASDAQ:SLN) for $20 per ADS, valuing its equity at approximately $1.3 billion.

Cytokinetics (NASDAQ:CYTK) received Health Canada approval for MYQORZO to treat adults with NYHA class II–III symptomatic obstructive hypertrophic cardiomyopathy, supported by 24-week trial results.

Mako Mining (NASDAQ:MAKO) recovered 12,743 ounces of gold in Q3 2026, generating approximately US$50 million in revenue from 11,581 ounces sold.

Chord Energy (NASDAQ:CHRD) reported preliminary third-quarter production of 290,500–290,900 barrels of oil equivalent daily, exceeding its guidance ceiling of 284,000 barrels.

AST SpaceMobile (NASDAQ:ASTS) welcomed a spectrum collaboration involving four European telecom operators, supporting its satellite connectivity strategy across a market exceeding 500 million subscribers.

Centrus Energy (NYSE:LEU) acquired Westerman Holdings for approximately $116 million, bringing manufacturing of centrifuge components into its operations.

EquipmentShare (NASDAQ:EQPT) raised its 2026 revenue forecast to $5.81–$6.05 billion, citing customer demand, fleet utilization and improving productivity.